loader

World Tenders & Procurement Opportunities

683943- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient Tocilizumab (exclusively pre-filled syringe and pre-filled pen), ATC L04AC07 for the period 01.12.2025 - 30.11.2027

World Biggest Tenders Source

This tender with title 683943- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient Tocilizumab (exclusively pre-filled syringe and pre-filled pen), ATC L04AC07 for the period 01.12.2025 - 30.11.2027 has been published on Bidding Source portal dated 20 Oct 2025 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

683943- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient Tocilizumab (exclusively pre-filled syringe and pre-filled pen), ATC L04AC07 for the period 01.12.2025 - 30.11.2027
Invitation for Bids
683943
Germany
20 Oct 2025
5 Oct 2027
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

685930- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient abiraterone (exclusively 500 mg 90 units), ATC L02BX03 for the period 01.12.2025 - 30.11.2027 Germany 685877- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient Aflibercept (excluding 114.3 mg/ml), ATC S01LA05 for the period 01.12.2025 - 30.11.2027 Germany 685328- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient Leuprorelin, ATC L02AE02 for the period 01.12.2025 - 30.11.2027 Germany 685244- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient Doravirine, ATC J05AG06 for the period 01.12.2025 - 30.11.2027 Germany 685134- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient Doravirine + Lamivudine + Tenofovir Disoproxil Fumarate, ATC J05AR24 for the period 01.12.2025 - 30.11.2027 Germany 684299- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient Natalizumab (exclusively in the Dafo. IFK), for the period 01.12.25 - 30.11.26 (plus extension option 1x12 months) Germany 684236- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient sumatriptan (excluding film-coated tablets and tablets), ATC N02CC01 for the period 01.12.2025 - 30.11.2027 Germany 683809- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient Haloperidol (injection solution only), ATC N05AD01 for the period 01.12.2025 - 30.11.2027 Germany 683790- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient tocilizumab (only concentrate for infusion solution), ATC L04AC07 for the period 01.12.2025 - 30.11.2027 Germany 685387- Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 SGB V for the aforementioned active ingredients with the option of concluding the agreement within the framework of the so-called open house procedure. Germany
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans